These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38338712)

  • 1. Special Issue "From Basic Science to Treatment Strategies: Personalized Cancer Therapy".
    Muminovic M; Hussein A; Raez LE
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional genomics for personalized cancer therapy.
    Tyner JW
    Sci Transl Med; 2014 Jul; 6(243):243fs26. PubMed ID: 24990879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Of art and science: is personalized medicine getting personal enough?
    Hendlisz A
    Curr Opin Oncol; 2015 Jul; 27(4):349-50. PubMed ID: 26049276
    [No Abstract]   [Full Text] [Related]  

  • 4. Epigenome-based personalized medicine in human cancer.
    Yan W; Herman JG; Guo M
    Epigenomics; 2016 Jan; 8(1):119-33. PubMed ID: 26344672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding the 'medicines' back into personalized medicine to improve cancer treatment outcomes.
    Martin JH; Phillips E; Thomas D; Somogyi AA
    Br J Clin Pharmacol; 2015 Nov; 80(5):929-31. PubMed ID: 26507561
    [No Abstract]   [Full Text] [Related]  

  • 6. An emerging role for cytopathology in precision oncology.
    Pauli C; Puca L; Mosquera JM; Robinson BD; Beltran H; Rubin MA; Rao RA
    Cancer Cytopathol; 2016 Mar; 124(3):167-73. PubMed ID: 26641771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioinformatics in Cancer Clinical Sequencing -- An Emerging Field of Cancer Personalized Medicine].
    Kato M
    Gan To Kagaku Ryoho; 2016 Apr; 43(4):391-7. PubMed ID: 27220783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving Toward a Precision-Based, Personalized Framework for Prevention Science: Introduction to the Special Issue.
    August GJ; Gewirtz A
    Prev Sci; 2019 Jan; 20(1):1-9. PubMed ID: 30362085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancer.
    Beckman RA; Schemmann GS; Yeang CH
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14586-91. PubMed ID: 22891318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine-molecular targeted cancer therapy.
    Osamura RY; Gown AM
    J Cell Mol Med; 2009; 13(11-12):4285. PubMed ID: 19691673
    [No Abstract]   [Full Text] [Related]  

  • 11. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
    Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
    Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics, personalized medicine, and supportive cancer care.
    Sonis ST
    Am Soc Clin Oncol Educ Book; 2015; ():9-16. PubMed ID: 25993135
    [No Abstract]   [Full Text] [Related]  

  • 13. Long range personalized cancer treatment strategies incorporating evolutionary dynamics.
    Yeang CH; Beckman RA
    Biol Direct; 2016 Oct; 11(1):56. PubMed ID: 27770811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics in the age of personalized medicine.
    Dickmann LJ; Ware JA
    Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personalized medicine in oncology: one drug, one biomarker].
    Díaz-Rubio García E
    An R Acad Nac Med (Madr); 2012; 129(1):371-85. PubMed ID: 24294735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steps forward for cancer precision medicine.
    Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
    Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer subtypes: morphologic and biologic characterization.
    Masood S
    Womens Health (Lond); 2016 Jan; 12(1):103-19. PubMed ID: 26756229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting cancer genomics in pet animals to gain advantage for personalized medicine decisions.
    Król M; Motyl T
    J Appl Genet; 2014 Aug; 55(3):337-41. PubMed ID: 24722858
    [No Abstract]   [Full Text] [Related]  

  • 19. BMC3PM: bioinformatics multidrug combination protocol for personalized precision medicine and its application in cancer treatment.
    Mokhtari M; Khoshbakht S; Akbari ME; Moravveji SS
    BMC Med Genomics; 2023 Dec; 16(1):328. PubMed ID: 38087279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming implementation challenges of personalized cancer therapy.
    Meric-Bernstam F; Mills GB
    Nat Rev Clin Oncol; 2012 Sep; 9(9):542-8. PubMed ID: 22850751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.